MDxHealth SA

Equities

MDXH

BE0974461940

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-06-14 pm EDT 5-day change 1st Jan Change
2.81 USD -0.35% Intraday chart for MDxHealth SA -2.43% -28.68%
Chart MDxHealth SA
More charts
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.81 USD
Average target price
7.25 USD
Spread / Average Target
+158.01%
Consensus
  1. Stock Market
  2. Equities
  3. MDXH Stock
  4. News MDxHealth SA
  5. MDxHealth Preliminary Q4 Revenue Tops Consensus; 2024 Outlook Exceeds Estimates; Shares Jump After Hours